Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Main Index

View All
octreotide LAR
Odomzo
ofatumumab Ofatumumab Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
olanzapine Common Regimens for Chemotherapy-Induced Nausea and Vomiting Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting:
olaparib Breast Cancer Olaparib Ovarian Cancer (Epithelial) Pancreatic Cancer Prostate Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
olutasidenib Olutasidenib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
omacetaxine
omacetaxine mepesuccinate
Oncaspar
Oncovin
ondansetron Common Regimens for Chemotherapy-Induced Nausea and Vomiting Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting: Common Regimens for Radiation-Induced Nausea and Vomiting:
Onivyde
Ontak
Opdivo
Opdualag
Orgovyx
Orserdu
OSI-774
osimertinib Lung Cancer Osimertinib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
osteogenic sarcoma
ovarian cancer epithelial germ cell
oxaliplatin Anal Cancer Biliary Tract Cancer Cancer of Unknown Primary Colorectal Cancer Esophageal Cancer Hepatocellular Cancer Lymphoma Oxaliplatin Pancreatic Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Testicular Cancer
paclitaxel
Padcev
palbociclib Breast Cancer Palbociclib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
palonosetron
pancreatic cancer
panitumumab Colorectal Cancer Panitumumab Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
panobinostat Multiple Myeloma Panobinostat
Paraplatin